Hidden in Plain Sight

Common Diseases Deserving Renewed Attention

In this new McDonald Minute NAXION CEO and author, Susan Schwartz McDonald, calls attention to problems only medical science can solve but insights functions can help reprioritize, by citing examples of prevalent conditions we checked off long ago but have merely satisficed.

Recently, I shared with a friend poised to begin treatment with Evenity the observation that all but one of the drugs used to treat osteoporosis have been available for over 15 years. Rheumatologists sometimes marvel at that. Evenity is the youngster of the armamentarium, launched in 2015, and insurance companies make it difficult to get it, even though a commonly used anabolic alternative like Prolia (and its biosimilars) isn’t easily stopped once started due to rebound effects not reversed by Evenity. In fact, my friend’s mighty struggle to get approval for Evenity as first-line therapy is what brought the topic up in the first place.

This article was published in the Fall of 2025
Susan Schwartz McDonald, Ph.D.

CEO, NAXION

Stay up to date With NAXION

Subscribe

This form uses Google reCaptcha | Terms • Privacy

See Your Way Forward

Contact Us
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Learn more about the cookies in use on this site.